Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Di

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
Nature Communications|October 2, 2025
Platelet activation plays a pro-inflammatory role in myasthenia gravisQi Wen, Shu Zhang, Yaye Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2011
The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?Stacey J Sukoff Rizzo, Sarah K Leonard, Adam Gilbert, et al.
Journal of Medicinal Chemistry|May 15, 2010
Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)Chiara Ghiron, Simon N Haydar, Suzan Aschmies, et al.
Scientific Reports|December 2, 2015
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)Kim Huard, Janice Brown, Jessica C Jones, et al.
Chirality|March 29, 2007
Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxesOliver McConnell, Alvin Bach, Carl Balibar, et al.
The Journal of Investigative Dermatology|April 24, 2025
Cholesterol pathway gene variants and reduced keratinocyte cholesterol support a final common druggable pathway in hyperproliferative inflammatory skin diseasesMelissa Riachi, Dale Bryant, James Ellis, et al.
QJM : Monthly Journal of the Association of Physicians|October 6, 2023
Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort studyJingsi Wang, Hongyu Zhou, Hongxi Chen, et al.
JCI Insight|June 7, 2019
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosaSu M Lwin, Farhatullah Syed, Wei-Li Di, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 19, 2021
Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotypeSatyamaanasa Polubothu, Davide Zecchin, Lara Al-Olabi, et al.
Science (New York, N.Y.)|November 2, 2021
An oral SARS-CoV-2 M<sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Nature Communications|October 2, 2025
Platelet activation plays a pro-inflammatory role in myasthenia gravisQi Wen, Shu Zhang, Yaye Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 22, 2011
The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?Stacey J Sukoff Rizzo, Sarah K Leonard, Adam Gilbert, et al.
Journal of Medicinal Chemistry|May 15, 2010
Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914)Chiara Ghiron, Simon N Haydar, Suzan Aschmies, et al.
Scientific Reports|December 2, 2015
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)Kim Huard, Janice Brown, Jessica C Jones, et al.
Chirality|March 29, 2007
Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery: building chiral technology toolboxesOliver McConnell, Alvin Bach, Carl Balibar, et al.
The Journal of Investigative Dermatology|April 24, 2025
Cholesterol pathway gene variants and reduced keratinocyte cholesterol support a final common druggable pathway in hyperproliferative inflammatory skin diseasesMelissa Riachi, Dale Bryant, James Ellis, et al.
QJM : Monthly Journal of the Association of Physicians|October 6, 2023
Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort studyJingsi Wang, Hongyu Zhou, Hongxi Chen, et al.
JCI Insight|June 7, 2019
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosaSu M Lwin, Farhatullah Syed, Wei-Li Di, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 19, 2021
Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotypeSatyamaanasa Polubothu, Davide Zecchin, Lara Al-Olabi, et al.
Science (New York, N.Y.)|November 2, 2021
An oral SARS-CoV-2 M<sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.
Pageof 30